We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$306M
AUM Growth
+$14.7M
Cap. Flow
+$3.51M
Cap. Flow %
1.15%
Top 10 Hldgs %
27.86%
Holding
219
New
21
Increased
61
Reduced
67
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 17.33%
2 Technology 16.22%
3 Consumer Discretionary 8.64%
4 Communication Services 7.87%
5 Financials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDB icon
1
MongoDB
MDB
$29.8B
$11.9M 3.9%
22,536
-686
-3% -$351K
AAPL icon
2
Apple
AAPL
$4.56T
$11.7M 3.82%
65,717
+285
+0.4% +$45K
IVV icon
3
iShares Core S&P 500 ETF
IVV
$897B
$10.3M 3.36%
21,557
-193
-0.9% -$88.9K
TPL icon
4
Texas Pacific Land
TPL
$24.5B
$9.89M 3.23%
71,253
+783
+1% +$109K
MGK icon
5
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
$8.59M 2.81%
164,665
+810
+0.5% +$41K
META icon
6
Meta Platforms (Facebook)
META
$1.5T
$7.44M 2.43%
22,118
-49
-0.2% -$16.3K
AMZN icon
7
Amazon
AMZN
$2.94T
$7.42M 2.43%
44,480
+280
+0.6% +$47.9K
GBT
8
DELISTED
Global Blood Therapeutics, Inc.
GBT
$6.16M 2.01%
210,350
-2,775
-1% -$86K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.38T
$6.03M 1.97%
41,640
+420
+1% +$60.5K
CVS icon
10
CVS Health
CVS
$123B
$5.77M 1.89%
55,936
+354
+0.6% +$32.7K
IYK icon
11
iShares US Consumer Staples ETF
IYK
$1.41B
$5.75M 1.88%
86,187
+15
+0% +$940
RLAY icon
12
Relay Therapeutics
RLAY
$4.3B
$5.68M 1.86%
185,063
ARCC icon
13
Ares Capital
ARCC
$14.1B
$5.28M 1.73%
248,971
-10,824
-4% -$225K
MRVL icon
14
Marvell Technology
MRVL
$189B
$4.7M 1.54%
53,661
-450
-0.8% -$33.6K
MSCI icon
15
MSCI
MSCI
$41.2B
$4.51M 1.48%
7,366
+422
+6% +$265K
LLY icon
16
Eli Lilly
LLY
$1.06T
$3.94M 1.29%
14,268
+25
+0.2% +$6.34K
DGRO icon
17
iShares Core Dividend Growth ETF
DGRO
$43.4B
$3.72M 1.22%
66,953
+422
+0.6% +$22.5K
UNP icon
18
Union Pacific
UNP
$175B
$3.69M 1.21%
14,642
-204
-1% -$48.3K
JNJ icon
19
Johnson & Johnson
JNJ
$619B
$3.5M 1.15%
20,473
+148
+0.7% +$24.2K
MO icon
20
Altria Group
MO
$113B
$3.44M 1.13%
72,702
-496
-0.7% -$22.7K
IWM icon
21
iShares Russell 2000 ETF
IWM
$82.1B
$3.44M 1.12%
15,445
+26
+0.2% +$5.88K
IJH icon
22
iShares Core S&P Mid-Cap ETF
IJH
$125B
$3.32M 1.09%
58,675
+185
+0.3% +$10.3K
IWB icon
23
iShares Russell 1000 ETF
IWB
$49.7B
$3.3M 1.08%
12,493
-67
-0.5% -$17.2K
V icon
24
Visa
V
$692B
$3.15M 1.03%
14,527
+245
+2% +$52.6K
GOOG icon
25
Alphabet (Google) Class C
GOOG
$4.36T
$3.08M 1.01%
21,260
-300
-1% -$43.4K

Similar funds

Fernwood Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Fernwood Investment Management held 219 positions worth $306M, up 5% from $291M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Fernwood Investment Management's Q4 2021 filing shows 21 new, 61 increased, 67 reduced and 8 closed positions. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 592 shares worth $882K. The largest sale was Acceleron Pharma, an estimated $1.62M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Fernwood Investment Management's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 592 shares worth $882K.
  • Fernwood Investment Management added most to Tesla in Q4 2021, an estimated $1.93M increase.
  • Fernwood Investment Management's biggest Q4 2021 reduction was Vanguard Real Estate ETF, cutting an estimated $411K.
  • Fernwood Investment Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $1.62M.
  • Fernwood Investment Management's ten largest holdings make up 28% of its $306M portfolio in Q4 2021.
  • Fernwood Investment Management opened 21 new positions and closed 8 in Q4 2021.
  • Fernwood Investment Management's portfolio value rose 5% quarter-over-quarter to $306M.

Based on Fernwood Investment Management's 13F filing for Q4 2021, filed 9 Feb 2022.